Geviti Appoints Dr. Kelly Brown, DO, as Medical Director

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Veteran Physician and Healthcare Executive Joins Leadership Team

Geviti, the AI-driven preventive health platform helping consumers identify health risks before disease develops, today announced the appointment of Dr. Kelly Brown, DO, as Medical Director.

Dr. Brown brings more than a decade of experience leading multidisciplinary clinical teams, overseeing healthcare operations, and advancing quality and patient safety initiatives across diverse care settings. A board-certified Family Medicine physician with advanced training in hormone optimization, longevity medicine, and root-cause approaches to chronic disease prevention, Dr. Brown has held leadership roles across both military and civilian healthcare — including service as a U.S. Navy Department Head and Medical Executive Committee Chair.

Dr. Brown joins Geviti at a pivotal moment for the company. Operating in 47 states and on the heels of an $8.5 million seed round closed in May 2025, Geviti launched its first-to-market Free AI Platform earlier this year, allowing consumers to upload bloodwork from any provider and receive AI-driven diagnostic insights at no cost. In her new role, Dr. Brown will oversee clinical quality initiatives, physician collaboration, patient safety protocols, and the continued development of Geviti's physician-guided preventive health programs.

"We shouldn't have to wait for disease to develop before we pay attention to health," said Dr. Brown. "By the time many diseases are diagnosed, the underlying process has often been unfolding for years. The future of medicine is identifying those signals earlier, when patients still have the opportunity to change the trajectory."

Geviti combines comprehensive bloodwork, gut testing, genetic testing, and artificial intelligence to provide consumers with a more complete understanding of their health. The platform is designed to identify potential risks earlier, helping patients make informed decisions alongside their healthcare providers.

"My father's story is what drove me to build Geviti — a platform that catches what routine care can miss," said Nathan Graville, Co-Founder and CEO of Geviti. "Dr. Brown brings the clinical leadership to make sure every patient we serve gets the rigor and personalized attention my father didn't get in time."

Dr. Brown's appointment is the first in a series of clinical leadership additions Geviti plans to announce as the company prepares for its Series A funding round and expands its physician-guided preventive health programs across all 50 states.

About Geviti

Geviti is an AI-driven preventive health platform combining advanced bloodwork, gut testing, genetic testing, and physician-guided insights to help individuals identify potential health risks before disease develops. Operating in 47 states with an $8.5 million seed round closed in May 2025, Geviti was co-founded by Nathan Graville and Elijah Fougnies and is headquartered in Phoenix, Arizona. The company's Free AI Platform allows any consumer to upload bloodwork from any provider and receive AI-driven diagnostic insights at no cost. Learn more at gogeviti.com.

"By the time many diseases are diagnosed, the underlying process has often been unfolding for years. The future of medicine is identifying those signals earlier, when patients still have the opportunity to change the trajectory." - Dr. Brown

Contacts

Media Contact: Melanie DeFilippis Coda Public Relations, on behalf of Geviti Melanie@codapr.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.56
-5.63 (-2.31%)
AAPL  293.47
+2.92 (1.00%)
AMD  453.37
-22.14 (-4.66%)
BAC  54.75
+0.33 (0.60%)
GOOG  354.44
-7.85 (-2.17%)
META  572.95
-11.64 (-1.99%)
MSFT  400.50
-2.91 (-0.72%)
NVDA  201.68
-6.51 (-3.13%)
ORCL  203.82
-1.99 (-0.96%)
TSLA  382.91
-13.77 (-3.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.